Skeletal muscle energy metabolism is severely impaired in insulin resistant and type 2 diabetic patients. In particular, deregulated transcription of oxidative metabolism genes has been linked to the development of non-communicable metabolic diseases. The peroxisome proliferator-activated receptor  (PPAR) coactivator-1 (PGC-1) is a key molecule in the regulation of oxidative metabolism in different tissues, including skeletal muscle. In this tissue, physical exercise is one of the most dominant physiological stimuli to induce PGC-1α. In addition, exercise training efficiently prevents the development of metabolic diseases. Hence, better knowledge about the regulation of PGC-1α by exercise would significantly help to design effective treatments for these diseases.
Introduction
Physical inactivity is nowadays considered as a pandemic, representing an important etiological factor in the development of non-communicable diseases and a major cause of premature death worldwide [1, 2] . The detrimental effects of a sedentary life style are largely associated with the impairment of skeletal muscle metabolic fitness, which is mainly characterized by a lower oxidative metabolism [3, 4] . Even though causality of mitochondrial dysfunction in the development of insulin resistance remains controversial, insulin-resistant and type 2 diabetic patients often present an impairment of skeletal muscle oxidative metabolism [5] . Is important to note that a pathological decrease in skeletal muscle insulin sensitivity is sufficient to promote the development of the metabolic syndrome [6, 7] . Therefore, the metabolic remodeling of skeletal muscle cells plays a central role in the pathogenesis of metabolic diseases like type 2 diabetes.
The development of obesity and type 2 diabetes largely depends on different environmental factors, including the balance between physical activity and inactivity [8] [9] [10] . At the transcriptional level, the peroxisome proliferator-activated receptor  (PPAR) coactivator-1 (PGC-1) plays a key role in exercise-linked mitochondrial remodeling [11, 12] . This coactivator regulates a specific transcriptional network, in which the estrogen related receptors (ERRs), nuclear respiratory factors (NRFs) and PPAR are the principal transcription factors involved in the enhancement of oxidative metabolism [11] . Consistent with its metabolic function, impairment of PGC-1 expression and activity have been identified as potential pathogenic factors in the development of insulin resistance and type 2 diabetes [5, 13, 14] . The expression of PGC-1 is sensitive to muscle contraction with high levels in trained subjects and a strong down-regulation in muscle from people with spinal cord injury [15] . Here, we review the specific mechanism by which different types of physical exercise regulate skeletal muscle PGC-1 and how this process is affected by non-communicable metabolic diseases.
Regulation of PGC-1 expression and activity by skeletal muscle contraction
Muscle contraction modulates different signal pathways that trigger the activation or repression of a very specific subset of genes, such as the slow-oxidative or fast-glycolytic gene program observed in type 1 and 2 skeletal muscle fibers, respectively [16] . PGC-1 specifically controls the expression of the slow-oxidative gene program, while the expression and activity of this coactivator is regulated by several protein kinases/phosphatases, transcription factors and coregulators in response to muscle contraction [12] .
Transcriptional regulation of PGC-1α in skeletal muscle
The human and mouse PGC-1 promoters contain a number of binding sites for different transcription factors, including PPARs, myocyte enhancer factor 2 (MEF2), activating transcription factor 2 (ATF2), forkhead box O1 (FOXO1), p53 and others [17] [18] [19] . Primarily however, muscle contraction mediates the activation of this promoter via the MEF2 binding sites and the cAMP response element (CRE) [20] . The transcriptional activity of MEF2 can be increased by PGC-1 or repressed by the histone deacetylase 5 (HDAC5) [18, 21] . Muscle contraction can decrease the inhibitory effect of HDAC5 through its phosphorylation by protein kinase D (PKD), 5'AMP-activated protein kinase (AMPK) and Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) [22] [23] [24] , representing an essential process in the activation of the PGC-1 promoter [22] . In contrast, PGC-1 is strongly induced by exercise (see below) and its positive effect on MEF2 has been suggested to activate a positive feedback loop, thus increasing its own transcription [18] . CRE binding protein (CREB) and ATF2 are the main transcription factors recruited to the CRE site in the PGC-1α promoter in response to muscle contraction [22] . Interestingly, both MEF2 and ATF2 are activated by p38 mitogen-activated protein kinase (MAPK) [25, 26] , indicating that this protein kinase is intimately involved in the regulation of PGC-1 transcription. Consistently, Pogozelski et al. [27] demonstrated that muscle-specific deletion of p38 MAPK completely blocked the up-regulation of PGC-1 induced by exercise. Accordingly, activation of p38 MAPK by reactive oxygen species (ROS) in response to exercise training is indeed an important mechanism regulating PGC-1 expression in skeletal muscle [28, 29] . Similarly, PKD activation is required for the activation of the PGC-1 promoter since the expression of a catalytic inactive form of PKD can fully prevent the effects of muscle contraction on PGC-1α expression [22] . In contrast to p38 MAPK and PKD, the relevance of AMPK and CaMKII in the regulation of PGC-1 expression by exercise has been more difficult to elucidate. For instance, muscle-specific deletion of the 1 and 2 subunits of AMPK significantly decreases the expression and activity of different mitochondrial enzymes during basal conditions, though it paradoxically results in higher levels of PGC-1 mRNA [30] while, to our knowledge, no studies exist that investigated the requirement for CaMKII for exercise-mediated regulation of PGC-1 expression. Interestingly, endurance exercise induces the activation p53 [31] , suggesting that it could promote the activation of the PGC-1 promoter. Moreover, a single bout of low-intensity endurance exercise results in higher mRNA levels of the transcription factors PPAR and FOXO1 [32] , both of which have been described to bind to the PGC-1 promoter [17, 19] . In particular, PPAR in complex with RXR can bind the PPAR response elements (PPRE) of the PGC-1 promoter and increase its transcriptional activity [19] . Considering that PGC-1 co-activates PPAR [33] , this could represent another positive feedback loop in the transcriptional regulation of this coactivator, but is currently unknown whether PPAR plays a significant role during endurance exercise.
More recently, novel mechanisms involving epigenetic modifications of the DNA and posttranscriptional regulation by microRNAs have been proposed to modulate PGC-1 transcription in response to exercise and pathological conditions. Interestingly, Barrès et al. [34] demonstrated that the DNA methyltransferase 3B (DNMT3B) could repress PGC-1 expression through non-CpG dinucleotide methylation of its promoter in human skeletal muscle. Importantly, the PGC-1 promoter was found to be hyper-methylated in skeletal muscle from impaired glucose-tolerant and type 2 diabetic patients, showing a negative correlation with PGC-1 mRNA levels and a decreased expression of several mitochondrial enzymes [34] . Inversely, acute exercise in human skeletal muscle and ex-vivo electrical stimulation of mouse skeletal muscle induce a significant decrease in the methylation levels of the PGC-1 promoter, which precede the increase in its transcript levels [35] .
Finally, physical activity and inactivity induce the down-and up-regulation of the microRNA miR-696, respectively, which negatively regulates PGC-1 expression in skeletal muscle [36] . Thus, overall, the PGC-1α promoter contains a high number of different transcription factor binding sites that control PGC-1α expression while the activation of additional signal pathways represent a potential mechanism by which PGC-1 transcript levels are further fine-tuned (Fig. 1A) .
Post-translational regulation of PGC-1α in skeletal muscle
In skeletal muscle, PGC-1 is a direct target of both AMPK and p38 MAPK, which both phosphorylate it at distinct sites and hereby induce its activation [37, 38] . Interestingly, it has been suggested that p38 MAPK-mediated phosphorylation and thereby stabilization of the PGC-1α protein precede transcriptional induction of PGC-1α gene expression in contracting muscle [39] . The balance between the acetylation and deacetylation of PGC-1 is controlled by the deacetylase sirtuin 1 (SIRT1) and the acetyl transferase general control of amino-acid synthesis 5 (GCN5), respectively [40, 41] . SIRT1-mediated deacetylation activates PGC-1 whereas GCN5 activity reverses this effect [40, 41] . Interestingly, activation of AMPK is a prerequisite for SIRT1-controlled deacetylation of PGC-1 in response to exercise [42] . Recently however, the relevance of SIRT1 for the modulation of muscle PGC-1 acetylation by exercise has been questioned since the skeletal muscle-specific genetic inactivation of SIRT1 did not affect deacetylation of PGC-1 and subsequent induction of its target genes in mouse skeletal muscle after acute and chronic exercise [43] . In this study, reduced interaction with GCN5 has been proposed as the main mechanism controlling the acetylation status of PGC-1α [43] . Interestingly, AMPK3 knockout mice exhibit impaired decrease of PGC-1 acetylation levels induced by exercise [42] , suggesting a potential role of AMPK in the regulation of PGC-1 acetylation by GCN5 rather than its deacetylation by SIRT1.
Effects of low-vs. high-intensity exercise on PGC-1

Endurance exercise
Physical activity represents one of the strongest physiological stimuli to promote skeletal muscle oxidative metabolism and stimulate PGC-1 expression. Initially, studies performed in rat skeletal muscle showed that 3 to 7 days of low-intensity swimming training could efficiently induce a ~2 fold increase in PGC-1 mRNA and protein content [44, 45] . Acutely, the completion of a total of 6 hours of low-intensity swimming or running resulted in a significant 2 to 7 fold increase in PGC-1 transcript and protein levels [45] [46] [47] . Similar to rodents, a single bout of endurance exercise also results in a 4 to 12 fold increase of PGC-1 mRNA in human skeletal muscle, an effect that is observed immediately after exercise up to 3 to 8 hours. Later, PGC-1α expression returns to basal levels within 4 to 24 hours post-exercise [31,32,48-51]. The magnitude by which acute endurance exercise modulate human skeletal muscle PGC-1 protein content is not well known, with some studies showing no increase 3 hours post-exercise [31,49] and others reporting a slight increase after endurance exercise to exhaustion [51] , indicating that the intensity at which exercise is performed could be an important factor. However, in humans, endurance training over a period of 6 weeks induces a significant ~2 fold increase of both mRNA and protein levels of muscle PGC-1 [52] . Interestingly, the activation of an alternative promoter of PGC-1 leads to the expression of different splice variant of this coactivator (PGC-1-a, PGC-1-b and PGC-1-c) in skeletal muscle [53, 54] . Of these three transcript variants, PGC-1-b exhibits a higher sensitivity to exercise and was indeed strongly up-regulated by endurance exercise in mouse skeletal muscle [53, 54] .
Furthermore, there is some evidence implying cytoplasmic-nuclear translocation to contribute to the regulation of PGC-1α, however this concept remains controversial. Interestingly, a splice variant called novel truncated PGC-1α (NT-PGC-1α), which lacks key domains in nuclear localization, is thought to shuttle between cytoplasm and the nucleus [55] . Other studies imply that in rat skeletal muscle, low-intensity swimming significantly increased the nuclear abundance of "normal" PGC-1 immediately after exercise [39] . In human skeletal muscle, a similar effect was reported, in which a ~54% increase in nuclear PGC-1 has been detected immediately after a single bout of endurance exercise [56] . In these studies, PGC-1 nuclear translocation after endurance exercise correlates with an increase in the phosphorylation levels p38 MAPK and its substrate ATF2 [39, 56] . Interestingly, whereas McGee & Hargreaves [57] did not detect PGC-1 nuclear translocation after a single bout of endurance exercise, they found a decrease and increase in the interaction between HDAC5 and PGC-1 with MEF2, respectively. Moreover, the exchange between HDAC5 and PGC-1 was also associated with an increase in p38 MAPK and MEF2 phosphorylation [57] . Furthermore, endurance exercise has been recently described to also increase PGC-1α levels in the mitochondrial matrix immediately after and 3 hours post-exercise [58] . Specifically, PGC-1 was detected in complex with the mitochondrial transcription factor A (TFAM) at the D-loop region of the mitochondrial DNA in the mitochondrial matrix and this interaction was further enhanced by endurance exercise [58] . Therefore, endurance exercise activates a broad spectrum of proteins involved in the expression, activation and maybe also the cellular localization of PGC-1.
Low-volume high-intensity interval training
During the last years, low-volume, high-intensity interval training (HIT) has been proposed as a timeefficient alternative to traditional endurance training to improve whole body and skeletal muscle oxidative metabolism [59] . For example, 6 weeks of low-volume HIT result in a higher VO 2peak , lower respiratory exchange ratio during exercise and increased activity of different mitochondrial enzymes (e.g. citrate synthase) in skeletal muscle [60] . Interestingly, the coactivator PGC-1 has also been considered as a potential mediator of the adaptations of energy metabolism to this kind of exercise training [59] . Accordingly, similar to low-intensity swimming, a single bout of high-intensity swimming in rats also induces a robust increase in skeletal muscle PGC-1 protein levels [61] . Importantly, in humans, a single bout of low-volume HIT has been showed to promote a 2 to 10 fold increase in skeletal muscle PGC-1 mRNA 3 to 4 hours post-exercise [31, [62] [63] [64] . It seems that the transient increase in PGC-1 mRNA after HIT precedes the subsequent increase of its protein levels 24 hours post-exercise [63, 64] . In fact, 3 hours after acute HIT, no increase in PGC-1 protein is detected [31, 62, 64] , further suggesting that mRNA levels need to be elevated before an increase at the protein level can be observed. In the long term, cycling low-volume HIT over a period of 2 to 6 weeks can induce a significant ~2 fold increase in total and nuclear muscle PGC-1 protein levels in recreationally active and sedentary subjects, thus to a similar extent as classical endurance training [60, 65, 66] . Even though HIT and endurance exercise result in similar effects on PGC-1 expression [60] , the fact that the training volume during HIT is substantially lower strongly suggests that PGC-1 is highly sensitive to exercise intensity. Recent published data from rodents and humans studies further support this idea showing that PGC-1 mRNA is increased to a higher extent by high-intensity compared to low-intensity exercise [53, 67, 68] .
Both chronic and acute low-volume HIT have been claimed to stimulate the translocation of PGC-1 from the cytosol to the nucleus, but different to endurance exercise, the acute effect is only detected 3 hours post-exercise in HIT [64, 66] . The translocation of PGC-1 induced by HIT is associated with higher p38 MAPK phosphorylation levels [64] . Interestingly, besides p38 MAPK, acute HIT also increases AMPK, CaMKII and p53 phosphorylation in skeletal muscle [31, 62, 64, 69] . Therefore, acute and chronic HIT activate the same signal pathways as endurance exercise (Fig. 1A) , but it has been proposed that exercise at high intensity results in stronger effects overall. In fact, Egan et al. [68] compared cycling exercise trials at 40 and 80% of the VO 2peak and showed that only high-intensity exercise induced a significant increase in AMPK, CaMKII, ATF2 and HDAC5 phosphorylation in skeletal muscle. Moreover, though both low-and high-intensity cycling increased PGC-1 mRNA, the effects of cycling at 80% of the VO 2peak were significantly higher than that at 40% of the VO 2peak [68] . Interestingly, HIT elevates SIRT1 expression in skeletal muscle [66] , suggesting that this kind of training modulates PGC-1 acetylation. Also similar to endurance training, HIT upregulates PPAR in skeletal muscle [63] . Finally, high-intensity exercise is more efficient in decreasing the methylation levels of the PGC-1 promoter [35] . These data suggest that the activation of additional signal pathways in response to high-intensity compared to low-intensity exercise would promote a higher increase of PGC-1 activity and expression, representing thus a more efficient strategy in terms of time and potency compared to traditional endurance training.
Impairment of exercise effects on PGC-1 in metabolic diseases
Low expression levels of skeletal muscle PGC-1 are characteristic of physically inactive people and type 2 diabetes patients [3,14,15,70]. Accordingly, modulation of the PGC-1 axis in skeletal muscle in metabolic diseases has been proposed to be impaired at different levels. De Filippis et al. [71] demonstrated that insulin resistant skeletal muscle is also "exercise resistant", since insulin resistant people exhibit diminished and delayed increase of PGC-1 expression in skeletal muscle after acute high-intensity exercise. However, endurance exercise at 40% or 70% of the VO 2max results in a normal increase in PGC-1 mRNA in human skeletal muscle from obese and type 2 diabetes patients [72] . Interestingly, only 7 days of bed rest completely blunt the induction of PGC-1 by acute exercise in human skeletal muscle [73] . In animals, an attenuated or abolished up-regulation of PGC-1 mRNA and its target genes after chronic exercise has been reported in skeletal muscle from both mouse and rat models suffering from the metabolic syndrome [74, 75] . The mechanism behind this response has been linked to impaired activation of AMPK by exercise, for example in acutely exercised mice fed a high fat diet [76] . In humans however, diminished induction of PGC-1 by high-intensity exercise was associated with normal activation of AMPK in insulin resistant subjects [71] , while normal induction of PGC-1 by low-intensity exercise was associated with impaired activation of AMPK in obese and type 2 diabetes patients [72] . Interestingly though, skeletal muscle from ob/ob mice shows no increase in AMPK phosphorylation, SIRT1 protein and PGC-1 mRNA levels after chronic exercise [75] . Furthermore, the decrease of PGC-1 acetylation induced by endurance training was impaired in ob/ob mice skeletal muscle [75] . In ob/ob mice skeletal muscle, ex vivo muscle contraction induces a slightly attenuated increase of p38 MAPK phosphorylation even though the effect was not significant compared to that observed in wild type animals [77] . However, despite of the lower levels of PGC-1 expression in type 2 diabetes patients [14], p38 MAPK phosphorylation seems to be elevated [78] . Altogether it appears that the effects of physical exercise on PGC-1 are negatively affected by metabolic diseases, affecting the expression and activation of this coactivator (Fig. 1A) .
Conclusions
Low-and high-intensity exercise positively modulates PGC-1 activity and expression through different signal pathways, in which p38 MAPK seems to play a central role (Fig. 1A) . This response to exercise seems to be impaired by physical inactivity and metabolic diseases (Fig. 1A) . Upon activation, PGC-1 not only enhance oxidative metabolism, but it also prevent muscle atrophy and improves ROS detoxification among other effects (Fig. 1B) . Hence, the modulation of this coactivator in muscle cells is an attractive approach for the treatment of metabolic diseases [79] , but it should be noted that as part of exercise-induced muscle plasticity, PGC-1 also enhances anabolic process such as de novo lipogenesis [80] (Fig. 1B) . Accordingly, elevation of muscle PGC-1α in sedentary, high fatfed mice accelerates the development of insulin resistance [81] . Importantly however, when combined with bona fide exercise, PGC-1 over-expression seems to be an efficient strategy to improve metabolic fitness under pathological conditions [82, 83] . Importantly, HIT appears to be a more efficient approach to induce PGC-1 in skeletal muscle and improve whole body energy metabolism [59] . In fact, low-volume HIT efficiently reduces blood glucose levels in type 2 diabetic patients [84] , further supporting its therapeutic effect. Therefore, the design of new therapies aiming to potentiate the effects of exercise on PGC-1 represents a potential path to combat noncommunicable metabolic diseases. Under pathological conditions such as a sedentary life style and obesity, PGC-1 expression is impaired due to aberrant activity and expression of negative and positive regulators (red circles) of this coactivator. In contrast, skeletal muscle contraction during low-and high-intensity exercise lead to the activation and inhibition of a subset of essential (blue circles) and accessory (grey circles) molecules involved in the control of the PGC-1 promoter activity, in addition to its post-translational modifications and thus protein activity. Consequently, physical activity results in the activation and up-regulation of this coactivator, thereby promoting an improvement of skeletal muscle metabolic fitness. Black and red arrows show activation and inhibition, respectively. (B) PGC-1 drives the activation of different putative transcription factors (TF), regulating thus different aspects of muscle physiology. In this figure, some of the most relevant effects of PGC-1 on skeletal muscle are shown (for more details, see ref. [85] ). Abbreviations: ERRα, estrogen-related receptor α; NRF1/2, nuclear respiratory factor 1 and 2; FoxO1/3, forkhead box O1/3; TFAM, mitochondrial transcription factor A; MEF2, myocyte enhancer factor 2; PPAR, peroxisome proliferator-activated receptor; RORα/γ, retinoic acid receptor-related orphan receptor α/γ; LXR, liver X receptor α; Nuclear factor-kappaB, NFB; RE, TF response elements.
